Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Elliott

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Mayo Clinic Proceedings|April 14, 2006
Atypical myeloproliferative disorders: diagnosis and managementAyalew Tefferi, Michelle A Elliott, Animesh Pardanani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantationRajesh M Prabhu, Michelle A Elliott, Robin Patel
The New England Journal of Medicine|March 1, 2002
Adverse events after imatinib mesylate therapyMichelle A Elliott, Ruben A Mesa, Ayalew Tefferi
Mayo Clinic Proceedings|July 13, 2004
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasiaRuben A Mesa, Michelle A Elliott, Georgene Schroeder, et al.
Haematologica|March 8, 2005
Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlatesShireen Sirhan, Terra L Lasho, Michelle A Elliott, et al.
Journal of Clinical Apheresis|October 31, 2009
Thrombotic microangiopathy during peripheral blood stem cell mobilizationHarris V K Naina, Morie A Gertz, Michelle A Elliott
American Journal of Hematology|January 15, 2014
CALR mutation studies in chronic neutrophilic leukemiaTerra L Lasho, Michelle A Elliott, Animesh Pardanani, et al.
Leukemia & Lymphoma|May 11, 2002
The prognostic significance of trisomy 8 in patients with acute myeloid leukemiaMichelle A Elliott, Louis Letendre, Curtis A Hanson, et al.
British Journal of Haematology|September 18, 2020
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patientsNaseema Gangat, Erika Morsia, James M Foran, et al.
Haematologica|July 20, 2004
FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophiliaAyalew Tefferi, Terra L Lasho, Stephanie R Brockman, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Mayo Clinic Proceedings|April 14, 2006
Atypical myeloproliferative disorders: diagnosis and managementAyalew Tefferi, Michelle A Elliott, Animesh Pardanani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2004
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantationRajesh M Prabhu, Michelle A Elliott, Robin Patel
The New England Journal of Medicine|March 1, 2002
Adverse events after imatinib mesylate therapyMichelle A Elliott, Ruben A Mesa, Ayalew Tefferi
Mayo Clinic Proceedings|July 13, 2004
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasiaRuben A Mesa, Michelle A Elliott, Georgene Schroeder, et al.
Haematologica|March 8, 2005
Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlatesShireen Sirhan, Terra L Lasho, Michelle A Elliott, et al.
Journal of Clinical Apheresis|October 31, 2009
Thrombotic microangiopathy during peripheral blood stem cell mobilizationHarris V K Naina, Morie A Gertz, Michelle A Elliott
American Journal of Hematology|January 15, 2014
CALR mutation studies in chronic neutrophilic leukemiaTerra L Lasho, Michelle A Elliott, Animesh Pardanani, et al.
Leukemia & Lymphoma|May 11, 2002
The prognostic significance of trisomy 8 in patients with acute myeloid leukemiaMichelle A Elliott, Louis Letendre, Curtis A Hanson, et al.
British Journal of Haematology|September 18, 2020
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patientsNaseema Gangat, Erika Morsia, James M Foran, et al.
Haematologica|July 20, 2004
FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophiliaAyalew Tefferi, Terra L Lasho, Stephanie R Brockman, et al.
Pageof 9